Open AccessPredictors of Hypertension Control in a Diverse General Cardiology Practice
Author(s) -
DeVore Adam D.,
Sorrentino Matthew,
Arnsdorf Morton F.,
Ward R. Parker,
Bakris George L.,
Blankstein Ron
Publication year - 2010
Publication title -
the journal of clinical hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.909
H-Index - 67
eISSN - 1751-7176
pISSN - 1524-6175
DOI - 10.1111/j.1751-7176.2010.00298.x
Subject(s) - medicine , odds ratio , blood pressure , confidence interval , cardiology , ethnic group , psychological intervention , odds , family medicine , logistic regression , nursing , sociology , anthropology
J Clin Hypertens(Greenwich). 2010;12:570–577. © 2010 Wiley Periodicals, Inc. Factors influencing hypertension (HTN) control in the United States are not well understood. The authors utilized a newly designed survey instrument to interview patients presenting to a diverse, general cardiology practice at a tertiary care center in order to identify factors associated with HTN control. The study was completed in 154 participants, and 121 (78.6%) had HTN. Of those, 111 (91.7%) had awareness of HTN, and 72 (59.5%) had HTN control, defined as <140/90 mm Hg. In a multivariate analysis, race/ethnicity was not associated with HTN control, but private insurance (odds ratio [OR] 3.40, 95% confidence interval [CI] 1.25–9.28), nonsmoker status (OR 4.36, CI 1.22–15.51), and number of medications used (OR 1.32, CI 1.12–1.56) were associated with HTN control. Correct recognition of systolic blood pressure goal and knowledge of one’s current state of HTN control were also associated with control. In conclusion, in a general cardiology practice where patients had a high degree of healthcare access, race/ethnicity was not associated with HTN control, while type of insurance, nonsmoker status, and increased number of medications used were associated. In addition, 2 novel predictors of HTN control, recognition of systolic blood pressure goal and knowledge of HTN control, were identified that can be utilized in creating new HTN treatment interventions.